UNIVERSITY OF ALABAMA AT BIRMINGHAM
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1969-01-01
- Employees
- 2K
- Market Cap
- -
- Website
- http://www.uab.edu
Novel Therapeutic Approaches for Treatment of CF Patients with W1282X Premature Termination Codon Mutations
Phase 4
Completed
- Conditions
- Cystic Fibrosis
- Interventions
- Drug: symdeko/TrikaftaDrug: Ivacaftor/TrikaftaDrug: Trikafta
- First Posted Date
- 2018-08-09
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 2
- Registration Number
- NCT03624101
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers
Early Phase 1
Withdrawn
- Conditions
- Neuroendocrine Carcinoma of PancreasCarcinoid
- Interventions
- First Posted Date
- 2018-08-09
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- University of Alabama at Birmingham
- Registration Number
- NCT03623984
- Locations
- 🇺🇸
UAB Kirklin Clinic, Birmingham, Alabama, United States
Magic Camp for Children With Hemiplegic Cerebral Palsy
Not Applicable
Completed
- Conditions
- Cerebral Palsy
- Interventions
- Behavioral: Magic camp intervention
- First Posted Date
- 2018-08-08
- Last Posted Date
- 2020-02-24
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 7
- Registration Number
- NCT03620279
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
A Multi-level Approach to Violence Prevention Among African American Adolescents
Not Applicable
Completed
- Conditions
- Violence in Adolescence
- Interventions
- Behavioral: Multi-level Violence Prevention Intervention - CaregiversBehavioral: Multi-level Violence Prevention Intervention - Boys
- First Posted Date
- 2018-08-06
- Last Posted Date
- 2019-08-05
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 32
- Registration Number
- NCT03615716
- Locations
- 🇺🇸
The University of Alabama at Birmingham, Birmingham, Alabama, United States
Embolization in Splenic Trauma
Not Applicable
Completed
- Conditions
- Trauma to the Spleen
- Interventions
- Device: Splenic artery embolization with vascular embolic coilsDevice: Splenic artery embolization with vascular embolic plugs
- First Posted Date
- 2018-08-03
- Last Posted Date
- 2021-08-11
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 48
- Registration Number
- NCT03613454
- Locations
- 🇺🇸
April Riddle, Harpersville, Alabama, United States
Novel Collagen Scaffold vs Conventional Scaffold in Regeneration of Human Dental Pulp Tissue
Phase 2
Withdrawn
- Conditions
- Root Canal Therapy
- Interventions
- Drug: Collagen-hydroxyapatite scaffold (Syn-Oss)Drug: Collagen Scaffold (Colla-Plug)
- First Posted Date
- 2018-08-02
- Last Posted Date
- 2019-05-23
- Lead Sponsor
- University of Alabama at Birmingham
- Registration Number
- NCT03613090
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Mixed Reality Gaming for Chronic Low Back Pain
Not Applicable
Completed
- Conditions
- Recurrent Low Back Pain
- Interventions
- Device: Exergaming
- First Posted Date
- 2018-07-27
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 13
- Registration Number
- NCT03603028
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Using Bluetooth Beacon Technology to Reduce Distracted Pedestrian Behavior
Not Applicable
Completed
- Conditions
- Health Behavior
- Interventions
- Behavioral: beacon alertsBehavioral: no alerts retention
- First Posted Date
- 2018-07-27
- Last Posted Date
- 2020-11-24
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 437
- Registration Number
- NCT03604497
- Locations
- 🇺🇸
UAB Youth Safety Lab, University of Alabama at Birmingham, Birmingham, Alabama, United States
Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer
Early Phase 1
Terminated
- Conditions
- Pancreatic CancerLocally Advanced Pancreatic CancerBorderline Pancreatic Inoperable Cancer
- Interventions
- Drug: Gemcitabine nab-PaclitaxelDrug: Folfirinox
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2020-08-18
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 25
- Registration Number
- NCT03600623
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis
Phase 4
Completed
- Conditions
- Psoriasis
- Interventions
- Drug: Metaderm
- First Posted Date
- 2018-07-24
- Last Posted Date
- 2023-12-15
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 11
- Registration Number
- NCT03597620
- Locations
- 🇺🇸
Dermatology at the Whitaker Clinic, Birmingham, Alabama, United States
© Copyright 2025. All Rights Reserved by MedPath